Perioperative issues in patients with cancer

Medical Clinics of North America

Volumn 87, Issue 1, 2003, Pages 243-256

  Manzullo, Ellen F ^a   Weed, Harrison G ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANAGRELIDE; ANTICOAGULANT AGENT; ANTINEOPLASTIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; BLEOMYCIN; BUSULFAN; CARMUSTINE; CHLORAMBUCIL; CHLORPROPAMIDE; CLOFIBRATE; CYCLOPHOSPHAMIDE; DEMECLOCYCLINE; DEXAMETHASONE; DOXORUBICIN; HEPARIN; LOMUSTINE; LOOP DIURETIC AGENT; METHOTREXATE; MORPHINE; NITROSOUREA DERIVATIVE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PARACETAMOL; SODIUM CHLORIDE; STEROID; THIAZIDE DIURETIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VINCRISTINE;

ADRENAL INSUFFICIENCY; AIRWAY OBSTRUCTION; ASTHMA; BLEEDING; BONE MARROW SUPPRESSION; BONE PAIN; BRAIN METASTASIS; BRONCHIOLITIS; CANCER CHEMOTHERAPY; CANCER PAIN; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER SURGERY; CARDIOMYOPATHY; CARDIOTOXICITY; COMPRESSION THERAPY; CONSTIPATION; DAILY LIFE ACTIVITY; DEEP VEIN THROMBOSIS; DELIRIUM; DIABETES MELLITUS; DOSE RESPONSE; DROWSINESS; DRUG CONTRAINDICATION; DRUG INDUCED DISEASE; GRANULOCYTOSIS; HEART VENTRICLE EXTRASYSTOLE; HIGH RISK PATIENT; HUMAN; HYPERCALCEMIA; HYPERCOAGULABILITY; HYPOMAGNESEMIA; HYPONATREMIA; INAPPROPRIATE VASOPRESSIN SECRETION; INSULIN RESISTANCE; INTERSTITIAL PNEUMONIA; LEG COMPRESSION; LIVER DYSFUNCTION; LIVER FIBROSIS; LIVER TOXICITY; LOEFFLER PNEUMONIA; LUNG EDEMA; LUNG FIBROSIS; LUNG TOXICITY; MALNUTRITION; MEDICAL DECISION MAKING; NEPHROTOXICITY; NEUTROPENIA; OSTEOPOROSIS; PATIENT REFERRAL; PERICARDIAL EFFUSION; PLEURA EFFUSION; POSTOPERATIVE COMPLICATION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; QRS COMPLEX; RADIATION DOSE; RADIATION SICKNESS; REVIEW; RISK ASSESSMENT; SCLEROSIS; SEDATION; SINUS TACHYCARDIA; ST SEGMENT; SUPRAVENTRICULAR PREMATURE BEAT; SURGICAL RISK; TASK PERFORMANCE; THORACOCENTESIS; THROMBOCYTE DYSFUNCTION; THROMBOCYTOSIS;

ANTINEOPLASTIC AGENTS; HUMANS; INTRAOPERATIVE COMPLICATIONS; NEOPLASMS; PERIOPERATIVE CARE; POSTOPERATIVE COMPLICATIONS; RADIATION INJURIES;

EID: 0037255209     PISSN: 00257125     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0025-7125(02)00157-8     Document Type: Review

References (48)

1. Daly JM, Decosse JJ. Principles of surgical oncology. In: Calabrese P, Schein PS, Rosenberg SA, editors. Medical oncology. Toronto: Macmillan; 1985. p. 261.
2. Fox KR. Surgery in the patient with cancer. In: Goldmann DR, Borwn FH, Guarnieri DM, editors. Perioperative medicine: medical care of the surgical patient. 2nd edition. New York: McGraw-Hill; 1994. p. 283-93.
3. Bickell NA, Young GJ. Coordination of care for early-stage breast cancer patients. J Gen Intern Med 2001;16:737-42.
4. Mor V, Laliberte L, Morris JN, Wiemann M. The Karnofsky Performance Status Scale: an examination of its reliability and validity in a research setting. Cancer 1984;53:2002-7.
5. McGeer AJ, Detsky A, O'Rourke K. Parenteral nutrition in cancer patients undergoing chemotherapy. Nutrition 1990;6:233-40.
6. Muller JM, Brenner V, Dienst C, et al. Preoperative parenteral feeding in patients with gastrointestinal carcinoma. Lancet 1982;1:68-71.
7. Heyland D, Novak J, Drover JW, et al. Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001;286:944-53.
8. Mackie AM, Watson CB. Anesthesia and mediastinal masses: a case report and review of the literature. Anaesthesia 1984;39:899-903.
9. Mathes DD, Bogdonoff DL. Preoperative evaluation of the cancer patient. In: Lefor AT, editor. Surgical problems affecting the patient with cancer: interdisciplinary management. Philadelphia: Lippincott-Raven; 1996. p. 273-304.
10. Lake CL. Anesthesia and pericardial disease. Anesth Analg 1983,62:431-43.
11. Reddy PS, Curtiss EI, O'Toole JD, et al. Cardiac tamponade: hemodynamic observations in man. Circulation 1978;58:256-72.
12. van Belle SJ, Volckaert A, Taeymans Y, et al. Treatment of malignant pericardial tamponade with sclerosis induced by instillation of bleomycin. Int J Cardiol 1987;16: 155-60.
13. Press OW, Livingston R. Management of malignant pericardial effusion and tamponade. JAMA 1987;257:1088-92.
14. Wang P, Wang KY, Chao JY, et al. Prognostic role of pericardial fluid cytology in cardiac tamponade associated with non-small cell lung cancer. Chest 2000; 118:744-9.
15. Tisi GM, editor. Arterial blood gases and pH. In: Pulmonary physiology in clinical medicine. Baltimore: Williams and Wilkins; 1980. p. 143.
16. Trump DL, Baylin SB. Ectopic hormone syndromes. In: Abeloff MD, editor. Complications of cancer: diagnosis and management. Baltimore: JHU Press; 1979. p. 211.
17. Sendak M. Monitoring and management of perioperative fluid and electrolyte therapy. In: Rogers MC, Tinker JH, Covino BG, editors. Principles and practice of anesthesiology. St. Louis: Mosby; 1992. p. 863.
18. Mundy GR, Martin TJ. The hypercalcemia of malignancy: pathogenesis and management. Metabolism 1982;31:1247-77.
19. Ralston S, Gallacher SJ, Patel U, et al. Cancer-associated hypercalcemia: morbidity and mortality: clinical experience in 126 treated patients. Ann Intern Med 1990;112:499-504.
20. Gunst MA, Drop LJ. Chronic hypercalcemia secondary to hyperparathyroidism: a risk factor for anesthesia? Br J Anaesth 1980;52:507-11.
21. Sieber FE. Evaluation of the patient with endocrine disease and diabetes mellitus. In: Rogers MC, Tinker JH, Covina BG, editors. Principles and practice of anesthesiology. St. Louis: Mosby; 1992. p. 285.
22. Rickles FR, Levine MN. Venous thromboembolism in malignancy and malignancy in venous thromboembolism. Haemostasis 1998;28(suppl 13):43-9.
23. Bergqvist D, Agnelli G, Cohen AT, et al. Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 2002;346:975-80.
24. Newton HB. Neurologic complications of systemic cancer. Am Fam Physician 1999;59: 878-86.
25. Lambert EH, Eaton LM, Rooke ED. Defect of neuromuscular conduction associated with malignant neoplasms. Am J Physical 1956;187:612-3.
26. McEvoy KM, Windebank AJ, Duabe JR, Low PA. 3, 4-Diaminopyridine in the treatment of Lambert-Eaton myasthenic syndrome. N Engl J Med 1989;321:1567-71.
27. Blum RH, Carter SK, Agre K. A clinical review of bleomycin - a new antineoplastic agent. Cancer 1973;31:903-14.
28. Einhorn LH, Krouse M, Hornback N, et al. Enhanced pulmonary toxicity with Neomycin and radiotherapy in oat cell lung cancer. Cancer 1976;37:2414-6.
29. Klein DS, Wilds PR. Pulmonary toxicity of antineoplastic agents: anesthetic and postoperative implications. Can Anaesth Soc J 1983;30:399-405.
30. Copper Jr JAD. Drug-induced lung disease. Adv Intern Med 1997;42:23-68.
31. Von Hoff DD, Rozencweig M, Piccart M. The cardiotoxicity of anticancer agents. Semin Oncol 1982;9:23-33.
32. Dahl MG, Gregory MM, Scheuer PJ. Methotrexate hepatotoxicity in psoriasis comparison of different dose regimens. BMJ 1972;1:654-6.
33. Schein PS, O'Connell MJ, Blom J, et al. Clinical antitumor activity and toxicity of streptozotocin (NSC085998). Cancer 1974;34:993-1000.
34. Gillette PC, Hill LL, Starling KA, Fernback DJ. Transient diabetes mellitus secondary to L-asparaginase therapy in acute leukemia. J Pediatr 1972,81:109-11.
35. Almawi WY, Tamim H, Azar ST. Clinical review 103: T helper type I and 2 cytokines mediate the onset and progression of type 1 (insulin-dependent) diabetes. J Clin Endocrinol Metab 1999;84:1497-502.
36. Fabris P, Betterle C, Greggio NA, et al. Insulin-dependent diabetes mellitus during alpha-interferon therapy for chronic viral hepatitis. J Hepatol 1998;28:514-7.
37. Coursin DB, Wood KE. Corticosteroid supplementation for adrenal insufficiency. JAMA 2002;287:236-40.
38. Grande C. Hypothyroidism following radiotherapy for head and neck cancer: multivariate analysis of risk factors. Radiother Oncol 1992;25:31-6.
39. Tami TA, Gomez P, Parkers GS, et al. Thyroid dysfunction after radiation therapy in head and neck cancer patients. Am J Otolaryngol 1992;13:357-62.
40. Hancock SL, Cox RS, McDougall IR. Thyroid diseases after treatment of Hodgkin's disease. N Engl J Med 1991;325:599-605.
41. Schimpff SC, Diggs CH, Wiswell JG, et al. Radiation-related thyroid dysfunction: implications for the treatment of Hodgkin's disease. Ann Intern Med 1980;92:91-8.
42. Peerboom PF, Hassink EA, Melkert R, et al. Thyroid function 10-18 years after mantle field irradiation for Hodgkin's disease. Eur J Cancer 1992;28A:1716-8.
43. Littley MD, Shalet SM, Beardwell CG. Radiation and hypothalamic-pituitary function. Baillieres Clin Endocrinol Metab 1990;4:147-75.
44. Rosenow EC. The spectrum of drug-induced pulmonary disease. Ann Intern Med 1972;77:977-91.
45. Goldiner PL, Schweizer O. The hazards of anesthesia and surgery in bleomycin-treated patients. Semin Oncol 1978;6:121-4.
46. Stewart JR, Fajardo LF. Radiation-induced heart disease: clinical and experimental aspects. Radiol Clin North Am 1971;9:511-31.
47. Morton DL, Kagan AR, Roberts WC, et al. Pericardiectomy for radiation-induced pericarditis with effusion. Ann Thorac Surg 1969;8:195-208.
48. Brosius FC, Waller BF, Roberts WC. Radiation heart disease: analysis of 16 young (aged 15 to 33 years) necroscopy patients who received over 3500 rads to the heart. Am Med 1981;70:519-30.